hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06275412 id: IRB-23-04-5675 id: 5R01MD018583-02 type: NIH link: https://reporter.nih.gov/quickSearch/5R01MD018583-02 briefTitle: Family Intervention for Black Teens With Type 1 Diabetes acronym: 3Ms overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2028-03 date: 2028-03 date: 2024-02-23 date: 2024-02-23 name: Wayne State University class: OTHER name: National Institute on Minority Health and Health Disparities (NIMHD) briefSummary: The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone). The intervention will also include new family intervention content (videoclips and text messages). conditions: Type 1 Diabetes conditions: Family Relations studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: CARE_PROVIDER count: 216 type: ESTIMATED name: The 3Ms 2.0 Intervention name: Educational Attention Control (EAC) measure: Glycemic Control measure: Caregiver Diabetes Distress measure: Diabetes-Specific Family Conflict measure: Diabetes-Specific Parental Monitoring measure: Diabetes-Specific Family Support measure: Illness Management measure: Intervention Satisfaction sex: ALL minimumAge: 10 Years maximumAge: 14 Years stdAges: CHILD facility: Children's National Hospital city: Washington state: District of Columbia zip: 20010 country: United States name: Angelica Eddington, Ph.D., ABPP role: CONTACT phone: 202-476-2342 email: aeddington@childrensnational.org name: Angelica Eddington, Ph.D., ABPP role: SUB_INVESTIGATOR lat: 38.89511 lon: -77.03637 facility: LeBonheur Children's Hospital city: Memphis state: Tennessee zip: 38103 country: United States name: Kristoffer S Berlin, Ph.D. role: CONTACT email: ksberlin@memphis.edu name: Kathryn Sumpter, MD role: SUB_INVESTIGATOR name: Kristoffer S Berlin, Ph.D. role: SUB_INVESTIGATOR lat: 35.14953 lon: -90.04898 facility: University of Tennessee Health Science Center-Memphis city: Memphis state: Tennessee zip: 38163 country: United States name: Kristoffer S Berlin, Ph.D. role: CONTACT email: ksberlin@memphis.edu name: Kathryn Sumpter, MD role: SUB_INVESTIGATOR name: Kristoffer S Berlin, Ph.D. role: SUB_INVESTIGATOR lat: 35.14953 lon: -90.04898 hasResults: False
nctId: NCT06275386 id: 2.31/II/24 briefTitle: Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention acronym: IMAGINATION overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2025-09-01 date: 2025-09-01 date: 2024-02-23 date: 2024-02-23 name: National Institute of Cardiology, Warsaw, Poland class: OTHER briefSummary: The IMAGINATION trial is an investigator-initiated, prospective, single-center study of symptomatic patients with a native chronic total occlusion (CTO) undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB). Post-PCI IVUS and fractional flow reserve (FFR) at baseline and at 6-months follow-up will be performed. In addition, patients included in the coronary computed tomography angiography (CCTA) substudy will undergo photon-counting CCTA at 12-months follow-up. The aim of this study is to evaluate the efficacy and safety of DCB-only approach in native coronary CTO. conditions: Coronary Artery Disease conditions: Total Occlusion of Coronary Artery studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 30 type: ESTIMATED name: Paclitaxel Drug-coated balloon measure: In-segment late lumen loss measure: Angiographic outcomes assessed directly post-PCI measure: HQ-IVUS outcomes assessed directly post-PCI measure: Physiologic outcomes assessed directly post-PCI measure: Angiographic outcomes at 6-months follow-up measure: HQ-IVUS outcomes at 6-months follow-up measure: Physiologic outcomes at 6-months follow-up measure: Computed tomographic outcomes at 12-months follow-up (CCTA substudy) measure: Clinical outcomes at 12-months follow-up sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National Institute of Cardiology city: Warsaw state: Mazowieckie zip: 04-628 country: Poland name: Agnieszka Zdziennicka role: CONTACT email: azdziennicka@ikard.pl lat: 52.22977 lon: 21.01178 hasResults: False
nctId: NCT06275373 id: 20-10974 briefTitle: The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction acronym: Teprotumumab overallStatus: RECRUITING date: 2021-05-12 date: 2026-05-12 date: 2027-12-12 date: 2024-02-23 date: 2024-02-23 name: Walter Reed National Military Medical Center class: FED briefSummary: This protocol studies the clinical outcome of patients with active thyroid disease with visually significant signs and symptoms of proptosis, pain, diplopiam lid/orbital edema, or lid/orbital erythema recommended for treatment with teprotumumab infusion (Tepezza®). Patients recommended for treatment will be evaluated by an oculoplastic surgeon (Dr. Eva Chou) and endocrinologist (Dr. Thanh Hoang). conditions: Thyroid Eye Disease conditions: Graves Ophthalmopathy conditions: Graves Disease studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 100 type: ESTIMATED name: Teprotumumab Injection [Tepezza] measure: Ophthalmological Clinical Activity Score (CAS) scoring measure: Thyroid stimulating immunoglobulin measure: HLA subtypes sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Walter Reed National Military Medical Center status: RECRUITING city: Bethesda state: Maryland zip: 20889 country: United States name: Thanh D Hoang, DO role: CONTACT phone: 301-295-5165 phoneExt: 6220 email: thanh.d.hoang.mil@health.mil name: Iris E Morris, PhD role: CONTACT phone: 3013194599 email: iris.e.morris3.civ@health.mil lat: 38.98067 lon: -77.10026 hasResults: False
nctId: NCT06275334 id: 9133 briefTitle: Dinutuximab Beta at the HUS and the Toulouse Oncopole acronym: DNB overallStatus: RECRUITING date: 2023-11-28 date: 2024-11 date: 2024-11-28 date: 2024-02-23 date: 2024-02-23 name: University Hospital, Strasbourg, France class: OTHER briefSummary: In this study the investigators wish to describe the cohort of pediatric patients suffering from neuroblastoma and treated with Dinutuximab and to compare the costs and quality of life between the two French centers, the University Hospital of Strasbourg (HUS) and the Oncopole of Toulouse. conditions: Neuroblastoma studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: RETROSPECTIVE count: 40 type: ESTIMATED measure: Comparison of two methods of treating a pediatric pathology in two French health establishments, the HUS and the Oncopole of Toulouse. sex: ALL minimumAge: 2 Years maximumAge: 25 Years stdAges: CHILD stdAges: ADULT facility: Service de Pharmacie - Stérilisation - CHU de Strasbourg - France status: RECRUITING city: Strasbourg zip: 67091 country: France name: Anne EL AATMANI, Pharm, PhD role: CONTACT phone: 33 3 88 12 78 06 email: Anne.ELAATMANI@chru-strasbourg.fr name: Emilie BERTHON, Pharm, PhD role: CONTACT phone: 33 3 88 12 78 06 email: emilieberthon@orange.fr name: Anne EL AATMANI, Pharm, PhD role: PRINCIPAL_INVESTIGATOR name: Emilie BERTHON, PhamD, PhD role: PRINCIPAL_INVESTIGATOR name: Sophie PERRIAT, PhamD, PhD role: PRINCIPAL_INVESTIGATOR lat: 48.58392 lon: 7.74553 hasResults: False
nctId: NCT06275321 id: Elena Garcia Roca briefTitle: Physical Exercise Benefits for Cancer Patients overallStatus: RECRUITING date: 2021-11-05 date: 2024-07-27 date: 2025-07-30 date: 2024-02-23 date: 2024-02-23 name: Universitat Jaume I class: OTHER briefSummary: The purpose of the study was to analyze the effect of a synchronous-supervised online home-based group during a 6-month exercise program on physical fitness, body composition and adherence compared to an exercise recommendation group of patients undergoing breast cancer treatment without supervision. conditions: Cancer, Breast conditions: Sports Physical Therapy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: A prospective ramonized clinical trial with two groups primaryPurpose: TREATMENT masking: SINGLE whoMasked: INVESTIGATOR count: 60 type: ESTIMATED name: Synchronous-supervised online home-based group name: Exercise recommendation group measure: Cardiorrespiratory fitness measure: Strength - Chair Stand (repetitions) measure: Flexibility measure: Incidence of treatments on quality of live assessed by EORTIC QLQ-C30 measure: Adherence measure: Rating of perceived exertion measure: Strength - Hand Grip (Kilograms) measure: Strength - Squat Jump (height in centimeters) sex: FEMALE minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Jaume I University status: RECRUITING city: Castellón De La Plana state: Castellón zip: 12071 country: Spain name: Elena Garcia Roca, MSc role: CONTACT phone: +34 629112367 email: garciroc@uji.es name: Eladio J Collado-Boira, PhD role: CONTACT phone: +34 606133368 email: colladoe@uji.es lat: 39.98567 lon: -0.04935 hasResults: False
nctId: NCT06275308 id: STUDY21100163 briefTitle: Effect of Raised End-Tidal pCo2 on Choroidal Volume overallStatus: RECRUITING date: 2023-02-27 date: 2025-02-27 date: 2025-02-27 date: 2024-02-23 date: 2024-02-23 name: University of Pittsburgh class: OTHER briefSummary: This study is to investigate the relationship between arterial carbon dioxide (CO2) concentration and vitreous pressure on the choroidal volume by integrated intraoperative OCT imaging under eye exams under anesthesia. conditions: Intraocular Pressure studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: This is a descriptive case series. primaryPurpose: BASIC_SCIENCE masking: NONE count: 20 type: ESTIMATED name: Ventilation manipulation measure: Intraocular Pressure (IOP) (mmHg) measure: Choroidal thickness ( microns) sex: ALL maximumAge: 8 Years stdAges: CHILD facility: University of Pittsburgh Medical Center status: RECRUITING city: Pittsburgh state: Pennsylvania zip: 15224 country: United States name: Amy Monroe, MPH, MBA role: CONTACT email: monroeal@upmc.edu name: Kanwal Nischal, MD,FRCOphth role: PRINCIPAL_INVESTIGATOR name: Lieu Tran, MD role: SUB_INVESTIGATOR lat: 40.44062 lon: -79.99589 hasResults: False
nctId: NCT06275295 id: ZRJY2021-BJ08-03-01-01 briefTitle: A Retrospective Study of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis overallStatus: NOT_YET_RECRUITING date: 2024-03-20 date: 2024-12-24 date: 2024-12-31 date: 2024-02-23 date: 2024-02-23 name: China-Japan Friendship Hospital class: OTHER briefSummary: The goal of this observational study is to learn about the diagnostic effectiveness, safety, and influencing factors of transbronchial cryobiopsy（TBLC） in progressive pulmonary fibrosis. conditions: Pulmonary Fibrosis conditions: Transbronchial Cryobiopsy studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: RETROSPECTIVE count: 300 type: ESTIMATED measure: The diagnostic rate of MDD2 based on TBLC measure: The diagnostic rate of MDD1 sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06275282 id: HUM00235849 briefTitle: Regenerative Peripheral Nerve Interfaces for the Control of Above-knee Prostheses overallStatus: RECRUITING date: 2024-03-01 date: 2027-06-30 date: 2027-09-30 date: 2024-02-23 date: 2024-03-25 name: University of Michigan class: OTHER name: United States Department of Defense briefSummary: Individuals with an above-knee lower limb amputation are known to walk more slowly, expend more energy, have a greater risk of falling, and have reduced quality of life compared to individuals without amputation and those with below knee amputation. One of the driving factors behind these deficits is the lack of active function provided by above-knee prostheses with prosthetic knees and ankles. While many prosthetic devices have been developed for functional restoration after major lower extremity amputation, there remains no stable interface to facilitate reliable, long-term volitional control of an advanced robotic limb capable moving multiple joints. Moreover, there is no existing interface that provides useful sensory feedback that in turn enhances the functional capabilities of the prosthesis. To achieve both greater signal specificity and long-term signal stability, we have developed a biologic interface known as the Regenerative Peripheral Nerve Interface (RPNI). An RPNI consists of a peripheral nerve that is implanted into a free muscle graft that would otherwise go unused in the residual limb. As the nerve grows, it reinnervates the free muscle graft which undergoes a predictable sequence of revascularization and regeneration.
3. Undergo explantation of electrodes following the conclusion of data collection. conditions: Amputation conditions: Prostheses and Implants studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: BASIC_SCIENCE masking: NONE count: 3 type: ESTIMATED name: Intramuscular electrodes measure: Intensity of pain in residual and phantom limbs measure: Neuropathic Pain in residual limb measure: Health-Related Quality of Life measure: Amplitude and signal-to-noise ratio for each RPNI measure: Classification accuracy for movements of the phantom limb measure: Threshold for sensation after electrical stimulation of RPNI sex: ALL minimumAge: 22 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Michigan status: RECRUITING city: Ann Arbor state: Michigan zip: 48109 country: United States name: Deanna Gates, PhD role: CONTACT phone: 723-647-2698 email: gatesd@umich.edu name: Deanna Gates, PhD role: PRINCIPAL_INVESTIGATOR lat: 42.27756 lon: -83.74088 hasResults: False
nctId: NCT06275269 id: ZRJY2021-BJ08-04-02 briefTitle: Endoscopic Mucosal Injection Versus Ultrasound-Guided Injection of Triamcinolone to Treat Subglottic Stenosis overallStatus: NOT_YET_RECRUITING date: 2024-03-10 date: 2024-10-31 date: 2024-12-31 date: 2024-02-23 date: 2024-02-23 name: China-Japan Friendship Hospital class: OTHER briefSummary: This study employs a multicenter, randomized controlled trial method, where patients meeting the inclusion criteria for subglottic stenosis are randomly divided into two groups. These groups are respectively undergoing translaryngeal endoscopic mucosal injection and ultrasound-guided injection of triamcinolone treatment. The comparison will focus on various indicators such as therapeutic effect, incidence of adverse reactions, treatment costs, and hospital resource utilization between the two groups. The safety and effectiveness will be compared to determine the relative merits of the two treatment methods. conditions: Subglottic Stenosis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 40 type: ESTIMATED name: Ultrasound-Guided name: Translaryngeal Endoscopic Mucosal Injection measure: Incidence of Short-Term Postoperative Complications measure: Overall medical expenses incurred by patients sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06275256 id: HS26226 briefTitle: Outcomes of MIST for BPH: A Single-Institution Prospective Study overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-03 date: 2025-03 date: 2024-02-23 date: 2024-02-23 name: University of Manitoba class: OTHER briefSummary: The investigators wish to perform a prospective study at the Men's Health Clinic in Winnipeg, Manitoba to accomplish two goals: 1) Prospectively describe 1 year outcomes for MIST therapies performed at the clinic 2) perform a head to head comparison of Rezum water vapor therapy vs the iTind device in respect to symptom score improvement, uroflow parameters and side effect profile. conditions: Benign Prostatic Hyperplasia studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 20 type: ESTIMATED name: Rezum name: iTind measure: Symptom Scores measure: Uroflow measure: Uroflow measure: Symptom Scores measure: Symptom Scores measure: Symptom Scores measure: Pain Scale sex: MALE minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Men's Health Clinic city: Winnipeg state: Manitoba zip: R3K 1M3 country: Canada name: Premal Patel, MD role: CONTACT phone: 204-221-4476 email: ppatel5@hsc.mb.ca name: Harliv Dhillon, BSc role: CONTACT phone: 2049904153 email: harlivmhc@gmail.com lat: 49.8844 lon: -97.14704 hasResults: False
nctId: NCT06275243 id: ETICA-ULE-021-2022 briefTitle: Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain) overallStatus: ACTIVE_NOT_RECRUITING date: 2022-07-06 date: 2023-03-13 date: 2024-03-22 date: 2024-02-23 date: 2024-02-23 name: Universidad de León class: OTHER name: Consejo General de Colegios Oficiales de Enfermería España briefSummary: The general objective of this randomized and longitudinal clinical study was to estimate the frequencies of ApoE variants both in the user population of the "Messengers of Peace" Residences and the "Associations of Relatives of Alzheimer's Patients" in Castile y Leon, since, due to its geographical location at the crossroads, it has received multiple genetic contributions from both northern Europe, the Mediterranean area and northern Africa.
* Is there a correlation between the ApoE4 variant and the lipid profile in the blood of individuals with Alzheimer's disease in this region? conditions: Alzheimer Disease studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: It is a longitudinal randomised clinical study, in which two study groups were used. A group of cases diagnosed with Alzheimer's disease and a control group of healthy individuals without Alzheimer's disease. primaryPurpose: DIAGNOSTIC masking: NONE count: 511 type: ACTUAL name: Kit Buccal swab collection & stabilization de Canvax® name: Cholesterol levels according to ApoE Genotype name: Assessing cardiovascular risk factors in all participants measure: Distribution of ApoE variants in the Alzheimer's disease population diagnosed in Castile and Leon. measure: Cardiovascular factors in individuals with Alzheimer's disease and healthy subjects. measure: ApoE genotypes and cholesterol levels in the Alzheimer's disease population diagnosed in Castile and Leon. sex: ALL minimumAge: 60 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of León city: León zip: 240071 country: Spain lat: 42.60003 lon: -5.57032 hasResults: False
nctId: NCT06275230 id: ZRJY2021-BJ08-02-07 briefTitle: Establishment of Human Lung Stem Cell Proliferation System and Organoid Construction in COPD overallStatus: NOT_YET_RECRUITING date: 2024-03-20 date: 2025-12-31 date: 2025-12-31 date: 2024-02-23 date: 2024-02-23 name: China-Japan Friendship Hospital class: OTHER briefSummary: The goal of this study is to proliferate human lung stem cell in vitro in order to establish a lung organoid derived from patients with COPD. The main question it aims to answer are:
* Can a lung organoid derived from patients with COPD be established. Participants will be sampled during pulmonary bronchoscope for organoid establishment. conditions: Chronic Obstructive Pulmonary Disease studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: CROSS_SECTIONAL count: 30 type: ESTIMATED measure: Number of Patients completed bronchoscope. sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT hasResults: False
nctId: NCT06275217 id: HMRF17182481 briefTitle: Mindful Yoga for Postpartum Depression overallStatus: RECRUITING date: 2021-01-08 date: 2025-07-15 date: 2025-12-31 date: 2024-02-23 date: 2024-02-23 name: The Hong Kong Polytechnic University class: OTHER briefSummary: This is a parallel-group randomized controlled trial. A total of 198 postpartum women with depressive symptoms (EPDS scores≥8 at baseline) will be recruited and randomized into two groups: 10-week mindful yoga intervention and 10-week psychoeducation program. Clinical assessment of depression, self-report questionnaires and salivary cortisol tests will be performed at baseline, after 10-week intervention, and at 6-month and 12-month follow-ups. The investigators expected that the mindful yoga intervention will reduce depression after 10 weeks compared to psychoeducation. The mindful yoga intervention will further reduce anxiety, stress, improve quality of life and sleep, and steepen diurnal cortisol slopes. These effects will be maintained for at least six months. conditions: Mood Disorders studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: OUTCOMES_ASSESSOR count: 198 type: ESTIMATED name: Mindfulness-based yoga program name: Psychoeducation measure: Edinburgh Postnatal Depression Scale measure: Depression Anxiety Stress Scale-Depression measure: Depression Anxiety Stress Scale-Anxiety measure: Depression Anxiety Stress Scale-Stress measure: Pittsburgh Sleep Quality Index measure: 36 Item-Short Form Health Survey Questionnaire measure: Five Facet Mindfulness Questionnaire measure: Pregnancy Symptom Inventory measure: Cortisol concentration level measure: Physical fitness measure: Balance sex: FEMALE minimumAge: 18 Years maximumAge: 60 Years stdAges: ADULT facility: The Hong Kong Polytechnic University status: RECRUITING city: Hong Kong country: Hong Kong name: Jessie JX Lin, PhD role: CONTACT email: jx-jessie.lin@polyu.edu.hk lat: 22.27832 lon: 114.17469 hasResults: False
nctId: NCT06275204 id: 101101252 id: 101101252 type: OTHER_GRANT domain: EU4H-2022-PJ-01 briefTitle: H. Pylori Screen-and-treat Study in a Population of Young Adults overallStatus: RECRUITING date: 2024-03-04 date: 2026-10-01 date: 2026-12-01 date: 2024-02-23 date: 2024-03-05 name: University of Latvia class: OTHER name: Clinical Hospital Center Rijeka name: Clinical Hospital Centre Zagreb name: Beacon Hospital name: Wroclaw Medical University name: Iuliu Hatieganu University of Medicine and Pharmacy name: National Institute of Public Health, Slovenia briefSummary: Gastric cancer remains a major challenge to public health on a global scale. H. pylori related cancer burden contributes to the largest proportion of cancer cases attributable to infections in Europe. Considering its absolute burden and persisting disparities, in addition to the substantial prevalence of H. pylori infection worldwide that is treatable, gastric cancer is a logical target for urgent action for prevention. Population-based H. pylori test-and-treat has therefore been proposed as a strategy for gastric cancer prevention. To fill the gaps in knowledge about gastric cancer prevention through H. pylori screening and eradication in younger adults, a study of a population-based H. pylori test-and-treat strategy in Ireland, Croatia, Latvia, Poland, Romania and Slovenia.
nctId: NCT06275191 id: 80758 id: 1UG3DE032621-01 type: NIH link: https://reporter.nih.gov/quickSearch/1UG3DE032621-01 id: 4UH3DE032621-02 type: NIH link: https://reporter.nih.gov/quickSearch/4UH3DE032621-02 briefTitle: Alternatives to Dental Opioid Prescribing After Tooth Extraction acronym: ADOPT overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2028-01 date: 2028-12 date: 2024-02-23 date: 2024-03-06 name: Douglas Oyler class: OTHER name: National Institute of Dental and Craniofacial Research (NIDCR) briefSummary: The goal of this clinical trial is to test a three-item intervention in oral surgeons who remove teeth. The main questions it aims to answer are: